BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22195852)

  • 1. Drug release from biodegradable polyesterurethanes with shape-memory effect.
    Feng Y; Zhang S; Wang H; Zhao H; Lu J; Guo J; Behl M; Lendlein A
    J Control Release; 2011 Nov; 152 Suppl 1():e20-1. PubMed ID: 22195852
    [No Abstract]   [Full Text] [Related]  

  • 2. Biodegradable polyesterurethanes with shape-memory properties for dexamethasone and aspirin controlled release.
    Feng Y; Zhang S; Wang H; Zhao H; Lu J; Guo J; Behl M; Lendlein A
    J Control Release; 2011 Nov; 152 Suppl 1():e21-3. PubMed ID: 22195859
    [No Abstract]   [Full Text] [Related]  

  • 3. Designing bioresorbable polyester matrices for controlled doxorubicin release in glioma therapy.
    Kasperczyk J; Stoklosa K; Dobrzynski P; Stepien K; Kaczmarczyk B; Dzierzega-Lecznar A
    Int J Pharm; 2009 Dec; 382(1-2):124-9. PubMed ID: 19715746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid based polyesteramides and polyesterurethanes: cell responsive matrices for drug delivery.
    Dias AA; Plum B; Mihov G; Turnell B
    J Control Release; 2011 Nov; 152 Suppl 1():e10-1. PubMed ID: 22195777
    [No Abstract]   [Full Text] [Related]  

  • 5. Preparation and evaluation of chitosan/carrageenan beads for controlled release of sodium diclofenac.
    Piyakulawat P; Praphairaksit N; Chantarasiri N; Muangsin N
    AAPS PharmSciTech; 2007 Nov; 8(4):E97. PubMed ID: 18181557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratin films from chicken feathers for controlled drug release.
    Li FY; Wang RM; He YF; Li XX; Song PF; Ying XC; Mao CW
    J Control Release; 2011 Nov; 152 Suppl 1():e92-3. PubMed ID: 22195951
    [No Abstract]   [Full Text] [Related]  

  • 7. Extrusion printed polymer structures: a facile and versatile approach to tailored drug delivery platforms.
    Rattanakit P; Moulton SE; Santiago KS; Liawruangrath S; Wallace GG
    Int J Pharm; 2012 Jan; 422(1-2):254-63. PubMed ID: 22101281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release of hydrogel modified textile products.
    Hu J
    J Control Release; 2011 Nov; 152 Suppl 1():e31-3. PubMed ID: 22195907
    [No Abstract]   [Full Text] [Related]  

  • 9. Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles.
    Klose D; Delplace C; Siepmann J
    Int J Pharm; 2011 Feb; 404(1-2):75-82. PubMed ID: 21056644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of aspirin/chitosan nanoparticles by nucleation and ionic crosslinking in micro emulsions.
    Jin S; Feng L; Yu X
    J Control Release; 2011 Nov; 152 Suppl 1():e39-41. PubMed ID: 22195912
    [No Abstract]   [Full Text] [Related]  

  • 12. Ammonolysis-based microencapsulation technique using isopropyl formate as dispersed solvent.
    Im HY; Sah H
    Int J Pharm; 2009 Dec; 382(1-2):130-8. PubMed ID: 19715744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain.
    Pillay S; Pillay V; Choonara YE; Naidoo D; Khan RA; du Toit LC; Ndesendo VM; Modi G; Danckwerts MP; Iyuke SE
    Int J Pharm; 2009 Dec; 382(1-2):277-90. PubMed ID: 19703530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation and controlled release of the inclusion complex of water soluble model drug neutral red with β-cyclodextrin grafted sodium alginate.
    Zhang S; Qiao X; Hu B; Gong Y
    J Control Release; 2011 Nov; 152 Suppl 1():e116-8. PubMed ID: 22195790
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel dual stimuli-responsive drug carrier biomaterial based on BSA/PVP polymers.
    Mao CW; Wang RM; Zhang HF; He YF; Tao JD; Ying XC
    J Control Release; 2011 Nov; 152 Suppl 1():e68-70. PubMed ID: 22195933
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro / in vivo evaluation of NCDS-micro-fabricated biodegradable implant.
    Park CW; Rhee YS; Park SH; Danh SD; Ahn SH; Chi SC; Park ES
    Arch Pharm Res; 2010 Mar; 33(3):427-32. PubMed ID: 20361308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A biodegradable filament for controlled drug delivery.
    Mack BC; Wright KW; Davis ME
    J Control Release; 2009 Nov; 139(3):205-11. PubMed ID: 19567255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
    Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
    Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microencapsulation of vitamin C by interfacial/emulsion reaction: characterization of release properties of microcapsules.
    Wang H; Shi H; Cheung AC; Xin JH
    J Control Release; 2011 Nov; 152 Suppl 1():e78-9. PubMed ID: 22195941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.